Lipoic acid: A novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS

Keyphrases

• Chronic Inflammatory Diseases 100%
• Multiple Sclerosis 100%
• Novel Therapeutics 100%
• α-lactalbumin (α-La) 100%
• Small Molecules 9%
• Antioxidant 9%
• Therapeutic Potential 9%
• Mitogen-activated Protein Kinase 9%
• Alzheimer's Disease 9%
• Prostaglandins 9%
• Signal Transduction Pathway 9%
• Oxidative Stress 9%
• Respiration 9%
• Biological Function 9%
• Biochemical Properties 9%
• Reactive Oxygen Species 9%
• Glucose Uptake 9%
• Antioxidant Properties 9%
• Stress Disorders 9%
• Chelates 9%
• Glutathione 9%
• Scavenger 9%
• Reduced Form 9%
• ERK MAP Kinase 9%
• Heavy Metals 9%
• Transition Metal Ions 9%
• Diabetic Neuropathy 9%
• Adenosine 5′-monophosphate 9%
• EP2 Receptor 9%
• Insulin Signaling 9%
• Dihydrolipoic Acid 9%
• Acetyl Coenzyme A (acetyl-CoA) 9%
• P38 MAP Kinase 9%
• Reactive Nitrogen Species 9%
• EP4 Receptor 9%
• Cellular Antioxidant 9%
• Insulin Analogues 9%
• Copper-zinc 9%
• Alzheime's Disease 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Disease 100%
• Multiple Sclerosis 100%
• Lipoic Acid 100%
• Antioxidant 27%
• Insulin 18%
• Alzheimer's Disease 9%
• Adenosine 9%
• Mitogen Activated Protein Kinase 9%
• Protein Kinase B 9%
• Glutathione 9%
• Reactive Oxygen Metabolite 9%
• Mitogen Activated Protein Kinase P38 9%
• Diabetic Neuropathy 9%
• Pyruvic Acid 9%
• Prostaglandin E Receptor 2 9%
• Prostaglandin E Receptor 4 9%
• Acetyl-CoA 9%
• Dihydrolipoic Acid 9%
• Heavy Metal 9%
• Transition Element 9%
• Reactive Nitrogen Species 9%
• Metal Ion 9%
• Diseases 9%
• Glucose 9%